Product image of Comirnaty Lp.8.1 (5'-Capped Mrna Encoding Sars-Cov-2, Variant Lp.8.1, Spike Protein, Pre-Fusion Stabilised (K981p And ) supplied by GNH India

Comirnaty Lp.8.1

Active Ingredient:
5'-Capped Mrna Encoding Sars-Cov-2, Variant Lp.8.1, Spike Protein, Pre-Fusion Stabilised (K981p And
Origin:
EU

Comirnaty Lp.8.1 (5'-Capped Mrna Encoding Sars-Cov-2, Variant Lp.8.1, Spike Protein, Pre-Fusion Stabilised (K981p And)

Comirnaty LP.8.1 is an mRNA vaccine designed to help prevent COVID-19 caused by the SARS-CoV-2 virus. It contains mRNA encoding the spike protein of the variant LP.8.1, administered via intramuscular injection. This vaccine is manufactured by BioNTech Manufacturing GmbH and is intended for use in eligible individuals.

Manufacturer / TM Owner

Biontech Manufacturing Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Comirnaty LP.8.1 is used to stimulate the immune system to produce a protective response against the SARS-CoV-2 virus, specifically the LP.8.1 variant. This vaccine is part of the broader effort to reduce the spread and severity of COVID-19. It is administered intramuscularly and is intended for use in individuals who meet the eligibility criteria as determined by healthcare providers.

Side Effects

  • Common effects of Comirnaty LP.8.1 may include temporary soreness, redness, or swelling at the injection site. Some individuals may experience fatigue, headache, muscle pain, chills, fever, or nausea following vaccination. These effects are generally mild to moderate and resolve within a few days.

Precautions & Warnings

  • Before receiving Comirnaty LP.8.1, individuals should inform their healthcare provider about any allergies, especially to any components of the vaccine. It is important to follow the storage and handling instructions provided by the manufacturer to ensure the vaccine's efficacy. Individuals should also be aware of any potential side effects and seek medical attention if severe reactions occur.

Avoid Interactions

  • Comirnaty LP.8.1 may interact with certain medications or medical conditions. It is important to discuss any current medications or health conditions with a healthcare provider before receiving the vaccine. Additionally, individuals should avoid alcohol and other substances that may affect the immune system's response to the vaccine.

Frequently Asked Questions

Comirnaty LP.8.1 is used to help prevent COVID-19 caused by the SARS-CoV-2 virus, specifically the LP.8.1 variant.

Comirnaty LP.8.1 is administered via intramuscular injection.

Common effects may include soreness at the injection site, fatigue, headache, muscle pain, chills, fever, or nausea.

Individuals with known allergies to any components of the vaccine should consult their healthcare provider before receiving Comirnaty LP.8.1.

Comirnaty LP.8.1 should be stored according to the manufacturer's instructions to maintain its efficacy.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing 5'-Capped Mrna Encoding Sars-Cov-2, Variant Lp.8.1, Spike Protein, Pre-Fusion Stabilised (K981p And

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT